Citations in PubMed

Primary Citation PubMed: 12434148 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 9

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

Conservation, variability and the modeling of active protein kinases.

(2007) PLoS One 2

PubMed: 17912359 | PubMedCentral: PMC1989141 | DOI: 10.1371/journal.pone.0000982

* Kinase Full name Species PDB code Pfam domain (residues) ACK1 activated CDC42 kinase 1 H. sapiens 1U54 [46] Protein tyrosine kinase (126-385) Akt2 RAC-β serine/threon... ne-protein kinase H. sapiens 1O6K [25] Protein kinase (152-409) CDK2 cell division protein kinase 2 H. sapiens 1JST [47] Protein kinase (4-286) CK1 casein kinase I S. pombe 1CSN [48] Protein kinase (12-237) CK2 casein kinase II subunit α Z. mays 1LP4 [49] Protein kinase (34-319) DAPK death-associated protein kinase H. sapiens 1IG1 [50] Protein kinase (13-275) IRK insulin receptor tyrosine kinase H. sapiens 1IR3 [51] Protein tyrosine kinase (1023-1290) MAPK p38γ mitogen-activated protein kinase p38γ H. sapiens 1CM8 [52] Protein kinase (27-311) PhK phosphorylase kinase O. cuniculus 1PHK [53] Protein kinase (19-287) Pim-1 proto-oncogene serine/threonine-protein kinase Pim-1 H. sapiens 1XR1 [54] Protein kinase (129-381) PKA protein kinase A M. musculus 1ATP [23] Protein kinase (43-297) PknB probable serine/threonine-protein kinase PknB M. tuberculosis 1MRU [55] Protein kinase (11-273) Rio2 Rio2 serine kinase A. fulgidus 1ZAO [56] Rio1 family (105-275) Sky1P SR protein kinase S. cerevisiae 1Q97 [57] Protein kinase (158-706) † TAO2 thousand and one amino-acid protein 2 R. norvegicus 1U5R [58] Protein kinase (28-281) ChaK ‡ transient receptor potential channel kinase M. musculus 1IA9 [2] Alpha kinase (1596-1814) * The average pair-wise sequence identity between this set as computed by ClustalW using its default parameters is 17%.

Publication Year: 2007


Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition.

(2009) PLoS Biol 7

PubMed: 19166270 | PubMedCentral: PMC2628406 | DOI: 10.1371/journal.pbio.1000017

The final model of the wild-type PH/KIN PKBα complex after molecular dynamics simulation was superimposed (kinase domain only) over the published X-ray structure of AKT-2 (PKBβ) �... b; 22 ] (PDB codes: 1O6K and 1O6L).

The only available crystal structure by Yang et al. (PDB code: 1O6K) [ 16 , 22 ] demonstrated that a modified HM (in which Ser 473 was mutated to an Asp) was positioned in a hydrophobic grove in the N lobe of the isolated active PKBβ kinase domain; the positioning of the HM in inactive full-length PKB has not been investigated.

The C-terminal was then mutated to correspond to the sequence of the C-terminal of PKBα, as below: 1O6K: Q R T HFPQF D YSAS I PKBα:RRPHFPQFSYSASG Underlined residues were mutated during the building (only three residues).

Publication Year: 2009


Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

(2009) PLoS One 4

PubMed: 19956600 | PubMedCentral: PMC2779450 | DOI: 10.1371/journal.pone.0008044

Secondary elements of the PKB (PDB code 1O6K) are shown in green and yellow.

Publication Year: 2009


Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

(2010) PLoS One 5

PubMed: 20844753 | PubMedCentral: PMC2937023 | DOI: 10.1371/journal.pone.0012661

Modeling phosphorylation of YB-1 by RSK A model of the RSK-CPP-binding complex was built on a known binding complex of AKT-GSK3β (PDB id 1o6k) [28] , using the Molsoft ICM 3.5-... m homology modeling and docking packages [29] .

Publication Year: 2010


Deciphering the Arginine-binding preferences at the substrate-binding groove of Ser/Thr kinases by computational surface mapping.

(2011) PLoS Comput Biol 7

PubMed: 22125489 | PubMedCentral: PMC3219626 | DOI: 10.1371/journal.pcbi.1002288

The four experimentally determined bound peptides are colored in cyan, blue, orange and magenta, for the PKB (1O6K), PKA (1JLU), PAK4 (2Q0N) and PIM1 (2BIL) kinases respectively.

Fortunately, the crystal structures (1O6K/1O6L) of the PKB-peptide complex show that our calculations are correct, and the P−5 Arg indeed reaches the −2 subsite.

For the peptide-unbound PKB structure (3D0E), the conformation of Glu170 uniquely and significantly deviated from the peptide-complex structure (1O6K) and from the consensus unbound conformation observed for the other kinases ( Figure 2 ).

Mean solution Most accurate solution Kinase family Kinase name Bound structure Unbound structure Model Rank ΔG [Kcal/mol] Cζ distance Model Rank RMSD (Å) 1 AGC PKA 1JLU 1BKX 1 −11.7 1.3 2 1.6 2 PKB a 1O6K 3D0E 1 (8) −7.4(−5.1) 1.7(1.7) 9 1.3 3 CAMK PIM1 2BIL 1XR1 1 −14.7 2.6 2 1.6 4 STE PAK4 2Q0N 2CDZ 1 −8.3 1.6 4 1.9 The RMSD between the ANCHORSmap-identified and the experimental Arg-binding positions was calculated over all heavy atoms of the Arg residue, apart from the Cβ atom.

Publication Year: 2011


A new synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), suppresses the Toll-like receptor 4-mediated inflammatory response through inhibition of the Akt/NF-?B pathway in BV2 microglial cells.

(2012) Exp Mol Med 44

PubMed: 22382990 | PubMedCentral: PMC3389075 | DOI: 10.3858/emm.2012.44.6.042

The three dimensional (3D) structure of Akt1 was obtained from the Protein Data Bank (PDB entry code: 1O6K; http://www.pdb.org ).

Publication Year: 2012


KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms.

(2013) Nucleic Acids Res 41

PubMed: 23193279 | PubMedCentral: PMC3531076 | DOI: 10.1093/nar/gks1218

To facilitate the observation, we constructed a pseudostructure with 14 anchors by combining six representative kinase structures (i.e. PDB codes 1AQ1 [CDK2], 3EQH [MAP2K1], 1O6K [AKT2], 2WGJ [MET], 3... S9 [ABL1] and 2HZ0 [ABL1]) and by eliminating the collision residues located near the bound inhibitors.

We then manually refined the structural alignments by visual inspection ( 41 ) to minimize the root-mean-square deviation of these 14 residues between the kinases and the template structure AKT2 structure (PDB code 1O6K).

Publication Year: 2013


Highly precise protein-protein interaction prediction based on consensus between template-based and de novo docking methods.

(2013) BMC Proc 7

PubMed: 24564962 | PubMedCentral: PMC4044902 | DOI: 10.1186/1753-6561-7-S7-S6

Table 1 Protein and PDB ID list of human apoptosis pathway dataset Protein Name PDB ID (_Chain) AIF 1M6I _A AKT1 1UNQ _A 3CQW _A 3O96 _A AKT2 1MRV _A 1O6K _A 1O6L _A 1P6S _A AKT3 2X18 _A APAF1 1CY5 _A... 1Z6T _A 2YGS _A 3IZA _A 3YGS _C BCL-2 2W3L _A 2XA0 _A BCL-XL 2B48 _A 3FDL _A BID 2BID _A 2KBW _B Bax 1F16 _A 2G5B _I 2XA0 _C 3PK1 _B CASP3 1RHQ _A 1RHQ _B 2DKO _A 2DKO _B 2J32 _A CASP6 2WDP _A CASP7 1F1J _A 1I4O _A 1I51 _A 1I51 _B 2QL9 _A 2QL9 _B CASP8 1QTN _A 1QTN _B 2FUN _B 3H11 _B CASP9 1JXQ _A 1NW9 _B 3D9T _C 3YGS _P Calpain1 1ZCM _A Calpain2 1KFU _L 2NQA _A Cn(CHP) 2E30 _A Cn(CHP2) 2BEC _A Cn(PPP3CA) 1AUI _A 1MF8 _A 2R28 _C 3LL8 _A Cn(PPP3R1) 1AUI _B 1MF8 _B 3LL8 _B CytC 1J3S _A DFF40 1IBX _A DFF45 1IBX _B 1IYR _A FADD 1A1W _A 2GF5 _A 3EZQ _B FLIP 3H11 _A Fas 3EWT _E 3EZQ _A IAP(BIRC2) 3D9T _A 3M1D _A 3MUP _A IAP(BIRC3) 2UVL _A 3EB5 _A 3EB6 _A 3M0A _D 3M0D _D IAP(BIRC4) 1G73 _C 1I4O _C 1I51 _E 1NW9 _A 2ECG _A 2KNA _A 2POI _A 3CM7 _C IκBα 1IKN _D 1NFI _E IKK 2JVX _A 3BRT _B 3BRV _B 3CL3 _D 3FX0 _A IL-1(A) 2ILA _A IL-1(B) 1ITB _A 2NVH _A 3O4O _A IL-1R(1) 1ITB _B IL-1R(RAP) 3O4O _B IL-3 1JLI _A IL-3R 1EGJ _A IRAK2 3MOP _K IRAK4 2NRU _A 3MOP _G MyD88 2JS7 _A 3MOP _A NF-κB(NFKB1) 1IKN _C 1NFI _B 1SVC _P 2DBF _A NF-κB(RELA) 1IKN _A 1NFI _A NGF 1WWW _V 2IFG _E PI3K(PIK3CA) 2ENQ _A 2V1Y _A 3HHM _A PI3K(PIK3CG) 1E8Y _A PI3K(PIK3R1) 1A0N _A 1H9O _A 1PBW _A 2IUG _A 2V1Y _B 3HHM _B 3I5R _A PI3K(PIK3R2) 2KT1 _A 2XS6 _A 3MTT _A PRKACA 3AGM _A PRKAR2A 2IZX _A TNFα 1A8M _A 4TSV _A TNF-R1 1EXT _A 1ICH _A TP53 1AIE _A 1OLG _A 1XQH _B 1YC5 _B 2B3G _B 2FOO _B 2GS0 _B 2K8F _B 2VUK _A 3D06 _A 3DAB _B 3LW1 _P TRADD 1F3V _A TRAF2 1CZZ _A 1D00 _A 1F3V _B 3KNV _A 3M0A _A 3M0D _A TRAIL 1D4V _B 1DG6 _A 1DU3 _D TRAIL-R 1D4V _A 1DU3 _A TrkA 1HE7 _A 1SHC _B 1WWW _X 2IFG _A The abbreviations used are: AIF, apoptosis-inducing factor, mitochondrion-associated, 1 (AIFM1); AKT1, RAC-alpha serine/threonine-protein kinase; AKT2, RAC-beta serine/threonine-protein kinase; AKT3, RAC-gamma serine/threonine-protein kinase; APAF1, apoptotic peptidase activating factor 1; BCL-2, B-cell lymphoma 2; BCL-XL, BCL extra-large; BID, BH3 interacting domain death agonist; Bax, BCL-2-associated × protein; CASP3/6/7/8/9, caspase-3/6/7/8/9; Cn(CHP), calcineurin B homologous protein 1; Cn(CHP2), calcineurin B homologous protein 2; Cn(PPP3CA), protein phosphatase 3 catalytic subunit alpha isoform; Cn(PPP3R1), protein phosphatase 3 regulatory subunit 1; CytC, cytochrome C; DFF40, DNA fragmentation factor, 40kDa, beta polypeptide; DFF45, DNA fragmentation factor, 45kDa, alpha polypeptide; FADD, Fas-associated via death domain; FLIP, FLICE/CASP8 inhibitory protein (CASP8 and FADD-like apoptosis regulator, CFLAR); Fas, tumor necrosis factor receptor (TNF) superfamily member 6; IAP, inhibitor of apoptosis; BIRC2/3/4, baculoviral IAP repeat-containing protein 2/3/4; IκBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha; IKK, inhibitor of nuclear factor kappa-B kinase; IL-1(A), interleukin-1 alpha; IL-1(B), interleukin-1 beta; IL-1R(1), type 1 interleukin-1 receptor; IL-1R(RAP), interleukin-1 receptor accessory protein; IL-3, interleukin-3; IL-3R, interleukin-3 receptor; IRAK2/4, interleukin-1 receptor-associated kinase 2/4; MyD88, myeloid differentiation primary response protein MyD88; NF-κB(NFKB1), nuclear factor of kappa light polypeptide gene enhancer in B-cells; NF-κB(RELA), nuclear factor of kappa light polypeptide gene enhancer in B-cells 3; NGF, nerve growth factor (beta polypeptide); PI3K, phosphatidylinositide 3-kinase; PIK3CA, PI3K subunit alpha; PIK3CG, PI3K subunit gamma; PIK3R1, PI3K regulatory subunit alpha; PIK3R2, PI3K regulatory subunit beta; PRKACA, cyclic adenosine monophosphate (cAMP)-dependent protein kinase catalytic subunit alpha; PRKAR2A, cAMP-dependent protein kinase type II-alpha regulatory subunit; TNFα, tumor necrosis factor; TNF-R1, TNF receptor superfamily member 1A; TP53, cellular tumor antigen p53; TRADD, TNF receptor type 1-associated death domain protein; TRAF2, TNF receptor-associated factor 2; TRAIL, TNF receptor superfamily member 10; TRAIL-R, TNF receptor superfamily member 10B; TrkA, neurotrophic tyrosine kinase receptor type 1.

Publication Year: 2013


PubMed ID is not available.

Published in 2015

PubMedCentral: PMC4428629

The panel shows the Cbk1–Mob2 complex superimposed with PKB, where the αC helix and the HM of the superimposed PKB are shown in yellow (PDB ID: 1O6K).

Cbk1’s disordered region containing αC was completed with the ordered region from the PKB/Akt’s crystal structure (PDB ID: 1O6K) using homology modeling followed by energy minimization to remove minor clashes.

Publication Year: 2015